You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

personalized cell therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • combinations of up to 3 FDA approved drugs from a panel of compounds
  • (no location specified)
Jan 19, 2023

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Camrelizumab (anti-PD-1 inhibitor)
  • Apatinib (anti-VEGFR inhibitor)
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

Molecular Testing for MD Anderson Cancer Center Personalized

Recruiting
  • Glioma
  • +4 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

Not yet recruiting
  • HPV-Negative Squamous Cell Carcinoma
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023

Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells

Not yet recruiting
  • Carcinoma
  • +3 more
  • Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
  • Chengdu, Sichuan, China
    West China Hospital
Feb 10, 2022

Gene Editing as a Therapeutic Approach for Rett Syndrome

Recruiting
  • Rett Syndrome
  • Gene editing in vitro
  • Siena, Italy
    University of Siena
Feb 13, 2023

Non Small Cell Lung Cancer Trial in Goyang-si (IP, GP)

Completed
  • Non Small Cell Lung Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center, Korea
Apr 4, 2022

Brain Metastases From NSCLC Trial (Stereotactic Radiation Therapy, Durvalumab)

Not yet recruiting
  • Brain Metastases From Non-small Cell Lung Cancer
  • (no location specified)
May 24, 2022

Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)

Recruiting
  • Smoldering Plasma Cell Myeloma
  • Biopsy Specimen Radiography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 12, 2021

Malignant Lung Tumor, Metastatic Malignant Tumor in the Lung, Non-Small Cell Lung Carcinoma Trial in Palo Alto (device, drug,

Active, not recruiting
  • Malignant Lung Neoplasm
  • +3 more
  • CAPP-Seq
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 31, 2022

Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic, Bladder Urothelial Carcinoma, Metastatic Trial in Herlev

Active, not recruiting
  • Malignant Melanoma, Metastatic
  • +2 more
  • Herlev, Denmark
  • +1 more
Jan 10, 2022

Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Lung Trial in Chicago (procedure, other,

Not yet recruiting
  • Lung Carcinoma
  • +5 more
  • Computed Tomography
  • +6 more
  • Chicago, Illinois
    Northwestern University
Mar 24, 2023

Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell

Active, not recruiting
  • Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
  • +2 more
  • Computed Tomography
  • +7 more
  • Seattle, Washington
  • +1 more
Jul 18, 2022

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

Recruiting
  • Advanced Renal Cell Carcinoma
  • IVAC
  • Heilbronn, Germany
    SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022

Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Blood sampling and urine analysis
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 28, 2023

NSCLC Stage IV Trial in Köln (DigiNet intervention)

Recruiting
  • Non-small Cell Lung Cancer Stage IV
  • DigiNet intervention
  • Köln, NRW, Germany
    Universitätsklinikum Köln
Apr 5, 2023

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Biospecimen Collection
  • Follow-Up
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Heart Failure, Mechanical Circulatory Support Trial in Ljubljana (CD34+ stem cell therapy)

Recruiting
  • Heart Failure
  • Mechanical Circulatory Support
  • CD34+ stem cell therapy
  • Ljubljana, Slovenia
    University Medical Center Ljubljana
Nov 22, 2023